Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

Many adverse drug reactions are thought to be caused by electrophilically reactive drug metabolites that conjugate to nucleophilic sites within DNA and proteins, causing cancer or toxic immune responses. Quinone species, including quinone-imines, quinone-methides, and imine-methides, are electrophilic Michael acceptors that are often highly reactive and comprise over 40% of all known reactive metabolites. Quinone metabolites are created by cytochromes P450 and peroxidases. For example, cytochromes P450 oxidize acetaminophen to N-acetyl-p-benzoquinone imine, which is electrophilically reactive and covalently binds to nucleophilic sites within proteins. This reactive quinone metabolite elicits a toxic immune response when acetaminophen exceeds a safe dose. Using a deep learning approach, this study reports the first published method for predicting quinone formation: the formation of a quinone species by metabolic oxidation. We model both one- and two-step quinone formation, enabling accurate quinone formation predictions in nonobvious cases. We predict atom pairs that form quinones with an AUC accuracy of 97.6%, and we identify molecules that form quinones with 88.2% AUC. By modeling the formation of quinones, one of the most common types of reactive metabolites, our method provides a rapid screening tool for a key drug toxicity risk. The XenoSite quinone formation model is available at http://swami.wustl.edu/xenosite/p/quinone .

[1]  J. Vervoort,et al.  Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. , 2000, Archives of biochemistry and biophysics.

[2]  E. Andrès,et al.  Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis , 2008, Expert opinion on drug safety.

[3]  Vladimir Poroikov,et al.  SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds , 2015, Bioinform..

[4]  Kristin P. Bennett,et al.  RS-Predictor: A New Tool for Predicting Sites of Cytochrome P450-Mediated Metabolism Applied to CYP 3A4 , 2011, J. Chem. Inf. Model..

[5]  J. Bauman,et al.  Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug , 2008, Drug Metabolism and Disposition.

[6]  David E. Gloriam,et al.  The SMARTCyp cytochrome P450 metabolism prediction server , 2010, Bioinform..

[7]  B. K. Park,et al.  The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine. , 1994, Journal of medicinal chemistry.

[8]  M. Meyer,et al.  Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. , 2010, Journal of mass spectrometry : JMS.

[9]  Alessandro Pedretti,et al.  Reactions and enzymes in the metabolism of drugs and other xenobiotics. , 2012, Drug discovery today.

[10]  Sanjay Joshua Swamidass,et al.  XenoSite server: a web-available site of metabolism prediction tool , 2015, Bioinform..

[11]  D. Ross,et al.  Generation of reactive species and fate of thiols during peroxidase-catalyzed metabolic activation of aromatic amines and phenols. , 1985, Environmental health perspectives.

[12]  J. Uetrecht,et al.  Animal models of idiosyncratic drug reactions. , 2004, Chemico-biological interactions.

[13]  W. Lutz,et al.  In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. , 1979, Mutation research.

[14]  W. Humphreys,et al.  Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry. , 2007, Chemical research in toxicology.

[15]  Kristin P. Bennett,et al.  RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes , 2012, J. Chem. Inf. Model..

[16]  Novel Bioactivation Mechanism of Reactive Metabolite Formation from Phenyl Methyl-Isoxazoles , 2012, Drug Metabolism and Disposition.

[17]  Vijay T. Ahuja,et al.  Identification and mitigation of a reactive metabolite liability associated with aminoimidazoles. , 2014, Chemical research in toxicology.

[18]  A. Breckenridge,et al.  Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat. , 1989, Biochemical pharmacology.

[19]  A. Wertheimer,et al.  Withdrawing Drugs in the U.S. Versus Other Countries , 2012 .

[20]  Sanjay Joshua Swamidass,et al.  A simple model predicts UGT-mediated metabolism , 2016, Bioinform..

[21]  C. Hasegawa,et al.  Structure–activity relationships of 2α-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  Vaibhav A. Dixit,et al.  Advances in Computational Prediction of Regioselective and Isoform‐Specific Drug Metabolism Catalyzed by CYP450s. , 2016 .

[23]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[24]  S. Knowles,et al.  Idiosyncratic drug reactions: the reactive metabolite syndromes , 2000, The Lancet.

[25]  T. Baillie,et al.  In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations , 2008, Drug Metabolism And Disposition.

[26]  S. Parapini,et al.  Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. , 2009, Journal of medicinal chemistry.

[27]  Sanjay Joshua Swamidass,et al.  RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules , 2013, Bioinform..

[28]  D. Dalvie,et al.  Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts. , 2009, Chemical research in toxicology.

[29]  Sanjay Joshua Swamidass,et al.  Extending P450 site-of-metabolism models with region-resolution data , 2015, Bioinform..

[30]  T. Schultz,et al.  Verification of the structural alerts for Michael acceptors. , 2007, Chemical research in toxicology.

[31]  David E. Gloriam,et al.  SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.

[32]  J. Palmblad,et al.  Drug-induced neutropenia--a survey for Stockholm 1973-1978. , 2009, Acta medica Scandinavica.

[33]  T. Monks,et al.  The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. , 2002, Current drug metabolism.

[34]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[35]  T. Surmann,et al.  [Cholestatic jaundice during flecainide therapy]. , 1984, Deutsche medizinische Wochenschrift.

[36]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  David Basketter,et al.  The chemistry of contact allergy: why is a molecule allergenic? , 1995, Contact dermatitis.

[38]  Chris Morley,et al.  Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit , 2008, Chemistry Central journal.

[39]  J. Mckim Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance , 2010, Combinatorial chemistry & high throughput screening.

[40]  J. Singer,et al.  The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated Patients , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[41]  R. Boulieu,et al.  High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[42]  M. Stephens The Dawn of Drug Safety , 2010 .

[43]  F. Guengerich,et al.  Mechanisms of drug toxicity and relevance to pharmaceutical development. , 2011, Drug metabolism and pharmacokinetics.

[44]  H. Nelis,et al.  Evidence for metabolic inertness of doxycycline. , 1981, Journal of pharmaceutical sciences.

[45]  J. Johnson,et al.  Biotransformation and elimination of 14C-flecainide acetate in humans. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[46]  B. K. Park,et al.  Immune pathomechanism of drug hypersensitivity reactions. , 2011, The Journal of allergy and clinical immunology.

[47]  Paolo Benedetti,et al.  Exposition and reactivity optimization to predict sites of metabolism in chemicals. , 2013, Drug discovery today. Technologies.

[48]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[49]  Sanjay Joshua Swamidass,et al.  XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks , 2013, J. Chem. Inf. Model..

[50]  Deepak Dalvie,et al.  Predicting toxicities of reactive metabolite-positive drug candidates. , 2015, Annual review of pharmacology and toxicology.

[51]  F. Lombardo,et al.  BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4 , 2005, Drug Metabolism and Disposition.

[52]  Pierre Baldi,et al.  A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval , 2010, Bioinform..

[53]  J. Schwöbel,et al.  Prediction of michael-type acceptor reactivity toward glutathione. , 2010, Chemical research in toxicology.

[54]  H. Gelboin Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[55]  G M Cohen,et al.  Quinone chemistry and toxicity. , 1992, Toxicology and applied pharmacology.

[56]  Lucija Peterlin Mašič,et al.  Bioactivation potential of thiophene-containing drugs. , 2014, Chemical research in toxicology.

[57]  J. Bolton,et al.  Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones. , 2004, Chemical research in toxicology.

[58]  G. Williamson,et al.  The C-glycosyl flavonoid, aspalathin, is absorbed, methylated and glucuronidated intact in humans. , 2009, Molecular nutrition & food research.

[59]  S. Joshua Swamidass,et al.  Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network , 2016, ACS central science.

[60]  Lars Olsen,et al.  Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms , 2012, ChemMedChem.

[61]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[62]  P. Moldéus,et al.  Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. , 1985, Molecular pharmacology.

[63]  K. Midha,et al.  Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[64]  W. M. Lee,et al.  Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.

[65]  Mingshe Zhu,et al.  Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering. , 2007, Analytical chemistry.

[66]  Dominic P. Williams,et al.  The Generation, Detection, and Effects of Reactive Drug Metabolites , 2013, Medicinal research reviews.

[67]  Yuan Chen,et al.  Metabolic Activation of Nevirapine in Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4 , 2009, Drug Metabolism and Disposition.

[68]  P. Anzenbacher,et al.  Cytochromes P450 and metabolism of xenobiotics , 2001, Cellular and Molecular Life Sciences CMLS.

[69]  Valérie Campagna-Slater,et al.  Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s , 2012, J. Chem. Inf. Model..

[70]  D. Lamb,et al.  Streptomyces cytochromes P450: applications in drug metabolism , 2013, Expert opinion on drug metabolism & toxicology.

[71]  Gabriele Cruciani,et al.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.

[72]  B. Meunier,et al.  Peroxidase-catalyzed O-demethylation reactions. Quinone-imine formation from 9-methoxyellipticine derivatives. , 1985, The Journal of biological chemistry.

[73]  Chang-Joon Lee,et al.  EaMEAD: Activation Energy Prediction of Cytochrome P450 Mediated Metabolism with Effective Atomic Descriptors , 2009, J. Chem. Inf. Model..

[74]  Jerome P. Charba,et al.  Skill in Precipitation Forecasting in the National Weather Service , 1980 .

[75]  Mehryar Mohri,et al.  Confidence Intervals for the Area Under the ROC Curve , 2004, NIPS.

[76]  Katie Chan,et al.  Structure–activity relationships for thiol reactivity and rat or human hepatocyte toxicity induced by substituted p‐benzoquinone compounds , 2008, Journal of applied toxicology : JAT.

[77]  A. Stepan,et al.  Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.

[78]  Pavel Hobza,et al.  On the performance of the semiempirical quantum mechanical PM6 and PM7 methods for noncovalent interactions , 2013 .

[79]  N. Kitteringham,et al.  Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. , 1988, Biochemical pharmacology.

[80]  Michael M. Mysinger,et al.  Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[81]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.

[82]  S. Joshua Swamidass,et al.  Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. , 2015, Chemical research in toxicology.

[83]  M. Mahajan,et al.  In Vitro Metabolism of Oxymetazoline: Evidence for Bioactivation to a Reactive Metabolite , 2011, Drug Metabolism and Disposition.

[84]  M. Kubo,et al.  Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.

[85]  B. Wen,et al.  Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s. , 2009, Chemico-biological interactions.

[86]  M. Numazawa,et al.  Biological aromatization of Δ4,6- and Δ1,4,6-androgens and their 6-alkyl analogs, potent inhibitors of aromatase , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[87]  E. Cavalieri,et al.  Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[88]  M. Cameron,et al.  Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways , 2009, Drug Metabolism and Disposition.

[89]  S. Joshua Swamidass,et al.  Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network , 2015, ACS central science.

[90]  Sanjay Joshua Swamidass,et al.  Improved Prediction of CYP-Mediated Metabolism with Chemical Fingerprints , 2015, J. Chem. Inf. Model..

[91]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[92]  P. Nguyen-Dinh,et al.  Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. , 1985, Life sciences.

[93]  H. Orhan Extrahepatic targets and cellular reactivity of drug metabolites. , 2014, Current medicinal chemistry.

[94]  J. Uetrecht,et al.  Bioactivation of Nevirapine to a Reactive Quinone Methide: Implications for Liver Injury , 2012, Chemical research in toxicology.

[95]  M. Lindquist,et al.  Quality criteria for early signals of possible adverse drug reactions , 1990, The Lancet.